Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Autoimmune Disorders

Free Subscription Articles published in Thyroid Retrieve available abstracts of 100 articles: HTML format

Single Articles

July 2021
1. PILLI T, Dalmazio G, Porcelli B, Cantara S, et al
   Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases.
   Thyroid. 2021 Jul 19. doi: 10.1089/thy.2021.0170.
   PubMed     Abstract available
   
   
   
2. OKAZAKI-HADA M, Maruoka A, Yamamoto M, Ito M, et al
   Poorly differentiated thyroid carcinoma coexisting with Graves' disease involving T3 thyrotoxicosis due to increased D1 and D2 activities.
   Thyroid. 2021 Jul 18. doi: 10.1089/thy.2021.0082.
   PubMed     Abstract available
   
   
   June 2021
3. RYDER M, Wentworth M, Algeciras-Schimnich A, Morris JC 3rd, et al
   Blocking the TSH receptor with K1-70 in a patient with follicular thyroid cancer, Graves' disease and Graves' ophthalmopathy.
   Thyroid. 2021 Jun 11. doi: 10.1089/thy.2021.0053.
   PubMed     Abstract available
   
   
   May 2021
4. KIM J, Choi MS, Park J, Park H, et al
   Changes in Thyroid Stimulating Hormone Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease.
   Thyroid. 2021 May 5. doi: 10.1089/thy.2020.0756.
   PubMed     Abstract available
   
   
   April 2021
5. SUZUKI N, Noh JY, Yoshimura R, Mikura K, et al
   Does age or sex relate to severity or treatment prognosis in Graves' disease?
   Thyroid. 2021 Apr 21. doi: 10.1089/thy.2020.0881.
   PubMed     Abstract available
   
   
   
6. VERA-LASTRA O, Ordinola Navarro A, Cruz Dominguez MP, Medina G, et al
   Two cases of Graves' disease following SARS-CoV-2 vaccination: An autoimmune/inflammatory syndrome induced by adjuvants.
   Thyroid. 2021 Apr 15. doi: 10.1089/thy.2021.0142.
   PubMed     Abstract available
   
   
   
7. 
   Correction to: Influence of Dietary Habits on Oxidative Stress Markers in Hashimoto's Thyroiditis by Ruggeri et al. Thyroid 2021;31:96-105. DOI: 10.1089/thy.2020.0299.
   Thyroid. 2021;31:709.
   PubMed    
   
   
   February 2021
8. RUGGERI RM
   Reply to Letter To The Editor: Influence of Dietary Habits on Oxidative Stress Markers In Hashimoto's Thyroiditis.
   Thyroid. 2021 Feb 17. doi: 10.1089/thy.2021.0065.
   PubMed     Abstract available
   
   
   
9. YUKSEL GULER B, Haymana C
   Letter To The Editor:Influence of Dietary Habits on Oxidative Stress Markers In Hashimoto's Thyroiditis.
   Thyroid. 2021 Feb 2. doi: 10.1089/thy.2021.0022.
   PubMed     Abstract available
   
   
   January 2021
10. KIM HJ, Kazmi SZ, Kang T, Sohn SY, et al
    Familial risk of Hashimoto's thyroiditis among first degree relatives, a population-based study in Korea .
    Thyroid. 2021 Jan 29. doi: 10.1089/thy.2020.0213.
    PubMed     Abstract available
    
    
    
11. JAYATISSA R, Okosieme O, Ranasinghe S, Carter JL, et al
    Thyroid autoimmunity and dysfunction in Sri Lankan children and adolescents after twenty two years of sustained universal salt iodisation.
    Thyroid. 2021 Jan 6. doi: 10.1089/thy.2020.0798.
    PubMed     Abstract available
    
    
    November 2020
12. JIANG W, Yu X, Kosik RO, Song Y, et al
    Gut microbiota may play a significant role in the pathogenesis of Graves' disease.
    Thyroid. 2020 Nov 24. doi: 10.1089/thy.2020.0193.
    PubMed     Abstract available
    
    
    
13. VANNUCCHI G, Campi I, Covelli D, Curro N, et al
    EFFICACY PROFILE AND SAFETY IMPLICATIONS OF VERY LOW DOSE RITUXIMAB IN PATIENTS WITH GRAVES' ORBITOPATHY.
    Thyroid. 2020 Nov 24. doi: 10.1089/thy.2020.0269.
    PubMed     Abstract available
    
    
    
14. DEGEN H, Gavvovidis I, Blankenstein T, Uhland K, et al
    TSHR-specific lymphocytes in Ad-TSHR-immunized native and HLA-DR3-transgenic mice and in Graves disease patient blood using MHCII tetramers.
    Thyroid. 2020 Nov 18. doi: 10.1089/thy.2020.0338.
    PubMed     Abstract available
    
    
    October 2020
15. ZHANG M, Ding X, Wu LP, He M, et al
    A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit.
    Thyroid. 2020 Oct 20. doi: 10.1089/thy.2020.0088.
    PubMed     Abstract available
    
    
    September 2020
16. CAMPI I, Curro N, Vannucchi G, Covelli D, et al
    QUANTIFICATION OF GLOBAL OCULAR MOTILITY IMPAIRMENT IN GRAVES' ORBITOPATHY BY MEASURING EYE MUSCLE DUCTIONS.
    Thyroid. 2020 Sep 17. doi: 10.1089/thy.2020.0165.
    PubMed     Abstract available
    
    
    
17. WANG N, Sun Y, Yang H, Xu Y, et al
    Hashimoto's thyroiditis induces hippocampus-dependent cognitive alterations by impairing astrocytes in euthyroid mice.
    Thyroid. 2020 Sep 10. doi: 10.1089/thy.2020.0139.
    PubMed     Abstract available
    
    
    August 2020
18. LI L, Ying YX, Liang J, Geng HF, et al
    Urinary iodine and genetic predisposition to Hashimoto's thyroiditis in a Chinese Han population: A case-control study.
    Thyroid. 2020 Aug 4. doi: 10.1089/thy.2020.0094.
    PubMed     Abstract available
    
    
    July 2020
19. NISHIO R, Uchida T, Suzuki L, Onose H, et al
    Influence of Short-term Dietary and Therapeutic Iodine Restriction on the Therapeutic Effects of Radioactive Iodine Therapy in Patients with Graves' Disease.
    Thyroid. 2020 Jul 30. doi: 10.1089/thy.2020.0126.
    PubMed     Abstract available
    
    
    
20. RUGGERI RM, Giovinazzo S, Barbalace MC, Cristani M, et al
    INFLUENCE OF DIETARY HABITS ON OXIDATIVE STRESS MARKERS IN HASHIMOTO'S THYROIDITIS.
    Thyroid. 2020 Jul 30. doi: 10.1089/thy.2020.0299.
    PubMed     Abstract available
    
    
    June 2020
21. 
    Correction to: Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study by Brito JP, Payne S, Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Sangaralingham LR, Iniguez-Ariza NM
    Thyroid. 2020;30:938.
    PubMed    
    
    
    March 2020
22. FAUSTINO LC, Li CW, Stefan M, Kim K, et al
    A novel mouse model of autoimmune thyroiditis induced by immunization with adenovirus containing full-length thyroglobulin cDNA: Implications to genetic studies of thyroid autoimmunity.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0711.
    PubMed     Abstract available
    
    
    
23. LIU Y, Cui X, Wang S, Liu J, et al
    Elevated microRNA-326 levels regulate the IL-23/IL-23R/Th17 cell axis in Hashimoto's thyroiditis by targeting a disintegrin and metalloprotease 17.
    Thyroid. 2020 Mar 24. doi: 10.1089/thy.2019.0552.
    PubMed     Abstract available
    
    
    
24. TAKYAR M, Rahmani M, Amouzegar A, Madreseh E, et al
    Parity and incidence of thyroid autoimmunity a population-based study Tehran thyroid study (TTS).
    Thyroid. 2020 Mar 11. doi: 10.1089/thy.2019.0440.
    PubMed     Abstract available
    
    
    
25. DUNTAS LH
    Back to the drawing board? Effects of high-dose vitamin D supplementation in Graves' disease on muscle strength, lean mass gain, and quality of life.
    Thyroid. 2020 Mar 2. doi: 10.1089/thy.2020.0162.
    PubMed     Abstract available
    
    
    February 2020
26. COOPER DS, Samuels M
    Hyperthyroidism and Dementia.
    Thyroid. 2020 Feb 26. doi: 10.1089/thy.2020.0136.
    PubMed     Abstract available
    
    
    
27. SEIB CD, Chen J, Iagaru A
    Shifting Trends and Informed Decision Making in the Management of Graves' Disease.
    Thyroid. 2020 Feb 11. doi: 10.1089/thy.2020.0114.
    PubMed     Abstract available
    
    
    January 2020
28. FOLKESTAD L, Brandt F, Lillevang-Johansen M, Brix TH, et al
    Graves' disease and toxic nodular goiter, aggravated by duration of hyperthyroidism, are associated with Alzheimer's and vascular dementia. A register-based long-term follow-up of two large cohorts.
    Thyroid. 2020 Jan 26. doi: 10.1089/thy.2019.0672.
    PubMed     Abstract available
    
    
    
29. BRITO JP, Payne S, Singh-Ospina N, Rodriguez-Gutierrez R, et al
    Patterns of use, efficacy and safety of treatment options for patients with Graves' disease: A Nationwide Population-Based Study.
    Thyroid. 2020 Jan 23. doi: 10.1089/thy.2019.0132.
    PubMed     Abstract available
    
    
    
30. PAPARODIS R, Karvounis E, Bantouna D, Chourpiliadis C, et al
    Incidentally discovered papillary thyroid microcarcinomas are more frequently found in patients with chronic lymphocytic thyroiditis than with multinodular goiter or Graves disease.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0347.
    PubMed     Abstract available
    
    
    
31. YOSHIHARA A, Noh JY, Watanabe N, Kunii Y, et al
    The characteristics of patients with Graves' disease whose thyroid hormone level increases after substituting potassium iodide for methimazole in the first trimester of pregnancy.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0392.
    PubMed     Abstract available
    
    
    
32. KE H, Hu J, Zhao L, Ding L, et al
    Impact of thyroid autoimmunity on ovarian reserve, pregnancy outcome, and offspring health in euthyroid women following in vitro fertilization/intracytoplasmic sperm injection.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2018.0657.
    PubMed     Abstract available
    
    
    
33. CELLINI M, Santaguida MG, Stramazzo I, Capriello S, et al
    RECURRENT PREGNANCY LOSS IN WOMEN WITH HASHIMOTO'S THYROIDITIS WITH CONCURRENT NON-ENDOCRINE AUTOIMMUNE DISORDERS.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0456.
    PubMed     Abstract available
    
    
    
34. WEIDER T, Richardson SJ, Morgan NG, Paulsen T, et al
    Upregulation of HLA class I and Antiviral Tissue Responses in Hashimoto's Thyroiditis.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0607.
    PubMed     Abstract available
    
    
    
35. FRANCA MM, Levine RL, Pappa T, Ilaka-Chibuluzo S, et al
    Non-autoimmune hyperthyroidism caused by a somatic mosaic GNAS gene mutation involving part of the thyroid gland.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0471.
    PubMed     Abstract available
    
    
    
36. GROVE-LAUGESEN D, Cramon PK, Malmstroem S, Ebbehoj E, et al
    Effects of supplemental vitamin D on muscle performance and quality of life in Graves' disease. A randomized clinical trial.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0634.
    PubMed     Abstract available
    
    
    December 2019
37. LI Y, Wang X, Liu Z, Ma J, et al
    Hashimoto's Thyroiditis with Increased IgG4-positive Plasma Cells: Using Thyroid-specific Diagnostic Criteria May Identify Early-Phase IgG4 Thyroiditis.
    Thyroid. 2019 Dec 20. doi: 10.1089/thy.2019.0063.
    PubMed     Abstract available
    
    
    
38. YEH MW
    The Year in Surgical Thyroidology, 2018-2019.
    Thyroid. 2019 Dec 16. doi: 10.1089/thy.2019.0767.
    PubMed     Abstract available
    
    
    
39. VANNUCCHI G, Covelli D, Campi I, Curro N, et al
    Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study.
    Thyroid. 2019;29:1828-1833.
    PubMed     Abstract available
    
    
    October 2019
40. SUZUKI N, Noh JY, Hiruma M, Kawaguchi A, et al
    Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan.
    Thyroid. 2019 Oct 1. doi: 10.1089/thy.2019.0045.
    PubMed     Abstract available
    
    
    September 2019
41. SJOLIN G, Holmberg M, Torring O, Bystrom K, et al
    The long-term outcome of treatment for Graves' hyperthyroidism.
    Thyroid. 2019 Sep 4. doi: 10.1089/thy.2019.0085.
    PubMed     Abstract available
    
    
    August 2019
42. SANTOS LR, Duraes C, Ziros PG, Pestana A, et al
    Interaction of genetic variations in <i>NFE2L2</i> and <i>SELENOS</i> modulates the risk of Hashimoto's thyroiditis.
    Thyroid. 2019 Aug 20. doi: 10.1089/thy.2018.0480.
    PubMed     Abstract available
    
    
    
43. ITO M, Kawasaki M, Danno H, Kohsaka K, et al
    Serum thyroid hormone balance in levothyroxine monotherapy-treated patients with atrophic thyroid after radioiodine treatment for Graves' disease.
    Thyroid. 2019 Aug 14. doi: 10.1089/thy.2019.0135.
    PubMed     Abstract available
    
    
    July 2019
44. AZIZI F, Amouzegar A, Tohidi M, Hedayati M, et al
    Increased remission rates after long-term methimazole therapy in patients with Graves' disease: Results of a randomized clinical trial.
    Thyroid. 2019 Jul 16. doi: 10.1089/thy.2019.0180.
    PubMed     Abstract available
    
    
    June 2019
45. PLOHN S, Hose M, Schluter A, Michel L, et al
    Fingolimod improves the outcome of experimental Graves' disease and associated orbitopathy by modulating the autoimmune response to the thyroid stimulating hormone receptor.
    Thyroid. 2019 Jun 25. doi: 10.1089/thy.2018.0754.
    PubMed     Abstract available
    
    
    
46. PEARCE SHS, Dayan C, Wraith DC, Barrell K, et al
    Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study.
    Thyroid. 2019 Jun 13. doi: 10.1089/thy.2019.0036.
    PubMed     Abstract available
    
    
    
47. MCLACHLAN SM, Aliesky H, Rapoport B
    A mouse TSH receptor A-subunit transgene expressed in thyroiditis-prone mice may provide insight into why Graves' disease only occurs in humans.
    Thyroid. 2019 Jun 11. doi: 10.1089/thy.2019.0260.
    PubMed     Abstract available
    
    
    May 2019
48. ABU-HELALAH M, Alshraideh HA, Al-Sarayreh SA, Al Shawabkeh AH, et al
    A cross-sectional study to assess the prevalence of adult Hypothyroidism and hyperthyroidism in Jordan.
    Thyroid. 2019 May 31. doi: 10.1089/thy.2018.0579.
    PubMed     Abstract available
    
    
    
49. EDO N, Kawakami K, Fujita Y, Morita K, et al
    Exosomes expressing thyrotropin receptor ameliorate autoantibody-mediated stimulation of cyclic adenosine monophosphate production.
    Thyroid. 2019 May 7. doi: 10.1089/thy.2018.0772.
    PubMed     Abstract available
    
    
    April 2019
50. HAN SY, Choi SH, Shin JS, Lee EJ, et al
    HMGB1 is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
    Thyroid. 2019 Apr 11. doi: 10.1089/thy.2018.0285.
    PubMed     Abstract available
    
    
    
51. GRULET H, Barraud S, Chikh K, Souchon PF, et al
    Three consecutive pregnancies in a patient with chronic autoimmune thyroid disease associated with hypothyroidism and extremely high levels of anti-TSH receptor antibodies.
    Thyroid. 2019 Apr 11. doi: 10.1089/thy.2018.0098.
    PubMed     Abstract available
    
    
    
52. HAN C, He X, Xia X, Guo J, et al
    Sphk1/S1P/S1PR1 signaling is involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2h4 Mice.
    Thyroid. 2019 Apr 9. doi: 10.1089/thy.2018.0065.
    PubMed     Abstract available
    
    
    
53. BELLASTELLA G, Caputo M, Maiorino MI, Longo M, et al
    EMPATHY: A new tool for identifying the most suitable thyroxine formulation in hypothyroid patients.
    Thyroid. 2019 Apr 9. doi: 10.1089/thy.2018.0493.
    PubMed     Abstract available
    
    
    March 2019
54. MALMSTROEM S, Grove-Laugesen D, Riis AL, Bruun BJ, et al
    Muscle performance and postural stability are reduced in patients with newly diagnosed Graves' disease.
    Thyroid. 2019 Mar 18. doi: 10.1089/thy.2018.0318.
    PubMed     Abstract available
    
    
    
55. DRAMAN MS, Morris D, Evans S, Haridas A, et al
    PROSTAGLANDIN F2-ALPHA EYE DROPS (BIMATOPROST) IN GRAVES' ORBITOPATHY: A RANDOMISED CONTROLLED DOUBLE MASKED CROSSOVER TRIAL (BIMA TRIAL).
    Thyroid. 2019 Mar 18. doi: 10.1089/thy.2018.0506.
    PubMed     Abstract available
    
    
    February 2019
56. FERNANDEZ-SANTOS JM, Utrilla JC, Vazquez-Roman V, Villar-Rodriguez JL, et al
    THE PRIMARY CILIUM IN THE HUMAN THYROCYTE: CHANGES IN FREQUENCY AND LENGTH IN RELATION TO THE FUNCTIONAL PATHOLOGY OF THE THYROID GLAND.
    Thyroid. 2019 Feb 15. doi: 10.1089/thy.2018.0401.
    PubMed     Abstract available
    
    
    
57. SCHRIJVER B, Kooiman MA, Kasteleijn E, van Holten-Neelen C, et al
    BASIC FIBROBLAST GROWTH FACTOR INDUCES ADIPOGENESIS IN ORBITAL FIBROBLASTS; IMPLICATION FOR THE PATHOGENESIS OF GRAVES' ORBITOPATHY.
    Thyroid. 2019 Feb 6. doi: 10.1089/thy.2018.0544.
    PubMed     Abstract available
    
    
    
58. 
    Correction to: Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years by Muller I, Willis M, Healy S, Nasser T, Loveless S, Butter
    Thyroid. 2019;29:309.
    PubMed    
    
    
    January 2019
59. EDMUNDS MR, Boelaert K
    Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
    Thyroid. 2019 Jan 28. doi: 10.1089/thy.2018.0665.
    PubMed     Abstract available
    
    
    
60. TORRING O, Watt T, Sjolin G, Bystrom K, et al
    Impaired quality of life after radioiodine therapy compared with antithyroid drugs or surgical treatment for Graves' hyperthyroidism. A long-term follow-up with ThyPRO and SF-36.
    Thyroid. 2019 Jan 22. doi: 10.1089/thy.2018.0315.
    PubMed     Abstract available
    
    
    
61. FASSBENDER J, Holthoff HP, Li Z, Ungerer M, et al
    Therapeutic effects of short cyclic and combined epitope peptides in a long-term model of Graves disease and orbitopathy.
    Thyroid. 2019 Jan 8. doi: 10.1089/thy.2018.0326.
    PubMed     Abstract available
    
    
    November 2018
62. YOSHIHARA A, Iwaku K, Noh JY, Watanabe N, et al
    Incidence of neonatal hyperthyroidism among newborns of Graves' disease patients treated with radioiodine therapy.
    Thyroid. 2018 Nov 14. doi: 10.1089/thy.2018.0165.
    PubMed     Abstract available
    
    
    
63. WANG W, Mao J, Zhao J, Lu J, et al
    Decreased Thyroid Peroxidase Antibody Titer in Response to Selenium Supplementation in Autoimmune Thyroiditis and the Influence of a SEPP Gene Polymorphism: A Prospective, Multicenter study in China.
    Thyroid. 2018 Nov 6. doi: 10.1089/thy.2017.0230.
    PubMed     Abstract available
    
    
    October 2018
64. BOESEN VB, Feldt-Rasmussen U, Bjorner JB, Cramon P, et al
    How should thyroid-related quality of life be assessed? Recalled patient-reported outcomes compared with here-and-now measures.
    Thyroid. 2018 Oct 27. doi: 10.1089/thy.2018.0210.
    PubMed     Abstract available
    
    
    
65. MARCINKOWSKI P, Hoyer I, Specker E, Furkert J, et al
    A new highly thyrotropin receptor-selective small molecule antagonist with potential for the treatment of Graves' orbitopathy.
    Thyroid. 2018 Oct 23. doi: 10.1089/thy.2018.0349.
    PubMed     Abstract available
    
    
    
66. MULLER I, Willis M, Healy S, Nasser T, et al
    Longitudinal characterization of autoantibodies to the thyrotropin receptor (TRAb) during alemtuzumab therapy; evidence that TRAb may precede thyroid dysfunction by many years.
    Thyroid. 2018 Oct 23. doi: 10.1089/thy.2018.0232.
    PubMed     Abstract available
    
    
    
67. DEKKER B, van der Horst-Schrivers ANA, Sluiter WJ, Brouwers AH, et al
    The clinical applicability of low levels of thyroglobulin autoantibodies (TgAbs) as cut-off point for TgAb positivity.
    Thyroid. 2018 Oct 23. doi: 10.1089/thy.2018.0195.
    PubMed     Abstract available
    
    
    August 2018
68. IYER PC, Cabanillas M, Waguespack SG, Hu MI, et al
    Immune Checkpoint Inhibitor mediated Thyroiditis.
    Thyroid. 2018 Aug 22. doi: 10.1089/thy.2018.0116.
    PubMed     Abstract available
    
    
    June 2018
69. KOREVAAR T, Minguez-Alarcon L, Messerlian C, de Poortere R, et al
    The association of thyroid function and autoimmunity with ovarian reserve in women seeking infertility care.
    Thyroid. 2018 Jun 26. doi: 10.1089/thy.2017.0582.
    PubMed     Abstract available
    
    
    April 2018
70. MARCUS-SAMUELS B, Krieger CC, Boutin A, Kahaly G, et al
    Evidence that Graves' Ophthalmopathy Immunoglobulins Do Not Directly Activate IGF-1 Receptors.
    Thyroid. 2018 Apr 10. doi: 10.1089/thy.2018.0089.
    PubMed     Abstract available
    
    
    
71. MCLACHLAN SM, Rapoport B
    A Role for Satb1 in Thyroid Autoimmunity?
    Thyroid. 2018 Apr 5. doi: 10.1089/thy.2017.0713.
    PubMed    
    
    
    March 2018
72. HAN YE, Hwang S, Kim JH, Byun JW, et al
    Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
    Thyroid. 2018 Mar 28. doi: 10.1089/thy.2017.0338.
    PubMed     Abstract available
    
    
    
73. GUO Q, Wu D, Yu H, Bao J, et al
    Alterations of Global DNA Methylation and DNA Methyltransferase Expression in T and B Lymphocytes from Patients with Newly Diagnosed Autoimmune Thyroid Diseases After Treatment: A Follow-Up Study.
    Thyroid. 2018;28:377-385.
    PubMed     Abstract available
    
    
    February 2018
74. LATROFA F, Ricci D, Bottai S, Brozzi F, et al
    Effect of thyroglobulin autoantibodies on the metabolic clearance of serum thyroglobulin.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0052.
    PubMed     Abstract available
    
    
    January 2018
75. YANG X, Lun Y, Jiang H, Liu X, et al
    SIRT1-regualted abnormal acetylation of FOXP3 induces Treg function defect in Hashimoto's thyroiditis.
    Thyroid. 2018 Jan 16. doi: 10.1089/thy.2017.0286.
    PubMed     Abstract available
    
    
    
76. PAPADAKIS GE, Lamine F, Chtioui H, Moschouri E, et al
    Rapid remission of Graves' hyperthyroidism without thionamides under immunosuppressive treatment for concomitant autoimmune hepatitis.
    Thyroid. 2018 Jan 16. doi: 10.1089/thy.2017.0613.
    PubMed     Abstract available
    
    
    
77. SABINI E, Mazzi B, Profilo MA, Mautone T, et al
    SERUM HIGH CHOLESTEROL IS A NOVEL RISK FACTOR FOR GRAVES' ORBITOPATHY (GO): RESULTS OF A CROSS-SECTIONAL STUDY.
    Thyroid. 2018 Jan 16. doi: 10.1089/thy.2017.0430.
    PubMed     Abstract available
    
    
    
78. VAN DIJK MM, Smits I, Fliers E, Bisschop PH, et al
    Maternal thyrotropin receptor antibody concentration and the risk of fetal and neonatal thyrotoxicosis: A systematic review.
    Thyroid. 2018 Jan 12. doi: 10.1089/thy.2017.0413.
    PubMed     Abstract available
    
    
    
79. ZHAO F, Feng J, Li J, Zhao L, et al
    Alterations of the gut microbiota in Hashimoto's thyroiditis patients.
    Thyroid. 2018 Jan 10. doi: 10.1089/thy.2017.0395.
    PubMed     Abstract available
    
    
    November 2017
80. WATANABE M, Takenaka Y, Honda C, Twin Research Group O, et al
    Genotype-based epigenetic differences in monozygotic twins discordant for positive anti-thyroglobulin autoantibodies.
    Thyroid. 2017 Nov 4. doi: 10.1089/thy.2017.0273.
    PubMed     Abstract available
    
    
    October 2017
81. YANG J, Yao LP, Dong M, Xu Q, et al
    Clinical characteristics and outcomes of propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis in patients with Graves' disease: A median 38-month retrospective cohort study from a single institution in China.
    Thyroid. 2017 Oct 31. doi: 10.1089/thy.2017.0468.
    PubMed     Abstract available
    
    
    
82. FERLOV-SCHWENSEN C, Brix TH, Hegedus L
    Death by suicide in Graves' disease and Graves' orbitopathy. A nationwide Danish register study.
    Thyroid. 2017 Oct 30. doi: 10.1089/thy.2017.0365.
    PubMed     Abstract available
    
    
    
83. HASHIMOTO K, Nishihara E, Matsumoto M, Matsumoto S, et al
    Sialic acid-binding immunoglobulin-like lectin1 as a Novel Predictive Biomarker for Relapse in Graves' Disease -A multicenter study.
    Thyroid. 2017 Oct 17. doi: 10.1089/thy.2017.0244.
    PubMed     Abstract available
    
    
    September 2017
84. GERSHENGORN MC
    No direct evidence for IGF-1 receptor (IGF-1R) stimulating antibodies in Graves' orbitopathy.
    Thyroid. 2017.
    PubMed     Abstract available
    
    
    August 2017
85. CHEN CW, Huang YL, Huang RL, Tzeng CR, et al
    Idiopathic low ovarian reserve is associated with more frequent positive thyroid peroxidase antibody.
    Thyroid. 2017 Aug 16. doi: 10.1089/thy.2017.0139.
    PubMed     Abstract available
    
    
    
86. YU SH, Kang JG, Kim CS, Ihm SH, et al
    Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.
    Thyroid. 2017 Aug 12. doi: 10.1089/thy.2017.0126.
    PubMed     Abstract available
    
    
    July 2017
87. SWEGAL WC, Chang SS, Singer MC
    Referral Trends for Surgical Management of Graves' Disease.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0145.
    PubMed     Abstract available
    
    
    
88. TORIMOTO K, Okada Y, Nakayamada S, Kubo S, et al
    Anti-PD-1 antibody therapy induces Hashimoto's disease with increase in peripheral blood follicular helper T cells.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0062.
    PubMed     Abstract available
    
    
    
89. AL-MAJDOUB M, Lantz M, Spegel P
    Treatment of Swedish Patients with Graves' Hyperthyroidism is Associated with Changes in Acylcarnitine Levels.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0218.
    PubMed     Abstract available
    
    
    June 2017
90. HAIDER U, Richards P, Gianoukakis A
    Thymic Hyperplasia Associated with Graves' Disease: Pathophysiology and Proposed Management Algorithm.
    Thyroid. 2017 Jun 3. doi: 10.1089/thy.2017.0086.
    PubMed     Abstract available
    
    
    May 2017
91. CHEN Y, Chen Y, Xia F, Wang N, et al
    A Higher Ratio of Estradiol to Testosterone is associated with Autoimmune Thyroid Disease in Males.
    Thyroid. 2017 May 30. doi: 10.1089/thy.2016.0661.
    PubMed     Abstract available
    
    
    
92. GIESECKE P, Rosenqvist M, Frykman V, Friberg L, et al
    Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
    Thyroid. 2017 May 4. doi: 10.1089/thy.2017.0029.
    PubMed     Abstract available
    
    
    April 2017
93. RUBIO GA, Koru-Sengul T, Vaghaiwalla TM, Parikh PP, et al
    Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.
    Thyroid. 2017 Apr 29. doi: 10.1089/thy.2016.0500.
    PubMed     Abstract available
    
    
    
94. LIU T, Sun J, Wang Z, Yang W, et al
    Changes in the DNA methylation and hydroxymethylation status of the intercellular adhesion molecule 1 gene promoter in thyrocytes from autoimmune thyroiditis patients.
    Thyroid. 2017 Apr 7. doi: 10.1089/thy.2016.0576.
    PubMed     Abstract available
    
    
    
95. KIM YA, Cho SW, Choi HS, Moon S, et al
    The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study.
    Thyroid. 2017;27:491-496.
    PubMed     Abstract available
    
    
    March 2017
96. LI C, Peng S, Liu X, Han C, et al
    Glycyrrhizin, a direct HMGB1 antagonist, ameliorates inflammatory infiltration in a model of autoimmune thyroiditis via inhibition of TLR2-HMGB1 signaling.
    Thyroid. 2017 Mar 31. doi: 10.1089/thy.2016.0432.
    PubMed     Abstract available
    
    
    January 2017
97. SUNDARESH V, Brito JP, Thapa P, Bahn RS, et al
    Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism - A Historical Cohort Study.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0343.
    PubMed     Abstract available
    
    
    September 2016
98. WU T, Mester T, Gupta S, Sun F, et al
    TSH and CD40L Stimulate Interleukin-12 Expression in Fibrocytes: Implications for pathogenesis of Thyroid Associated Ophthalmopathy.
    Thyroid. 2016.
    PubMed     Abstract available
    
    
    August 2016
99. TETI C, Nazzari E, Galletti M, Mandolfino MG, et al
    Unexpected elevated free thyroid hormones in pregnancy.
    Thyroid. 2016.
    PubMed     Abstract available
    
    
    July 2016
100. CRAMON P, Winther KH, Watt T, Bonnema SJ, et al
     Quality of life impairments persist six months after treatment of Graves' hyperthyroidism and toxic nodular goiter: A prospective cohort study.
     Thyroid. 2016.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: